Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

A Drug Discovery and Target Identification Screening Platform for Age-Associated Neurodegenerative Disorders

NeuronAgeScreen

Battling human neurodegenerative pathologies, and their pervasive societal impact, is a global multi-billion Euro enterprise. Ageing is universally associated with marked decrease of neuronal function and higher susceptibility to neurodegeneration. In human populations, this is manifested as an ever-increasing prevalence of devastating...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease

NILVAD

Alzheimer’s disease (AD) is an ever-increasing public health concern among the aging population and is the most common form of dementia affecting more than 15 million individuals worldwide and around 5 million Europeans. The direct and indirect costs of AD and other dementias amount to more than €440,000 million each year (www.alz.org, 2010).Even...

Funding Programme
Start Date
End Date
Total Funding
€ 7 916 016

A technology pLatform for the Assisted living of Dementia elDerly INdividuals and their carers

ALLADIN

The aim of the project is to utilise state-of-the-art in ICT in order to develop an integrated solution for the  self-management of dementia patients, and develop innovative tools to support this procedure. This  solution can be conceived as an integrated platform enabling distant monitoring of patient status and  facilitating personalised...

Funding Programme
Start Date
End Date
Total Funding
€ 1 980 757
European Countries Involved

a toolkit for dynaMic health Impact analysiS to predicT disability-Related costs in the Aging population based on three case studies of steeL-industry exposed areas in europe

MISTRAL

The environment is one of the most crucial determinants of health. The Global Burden of Disease report estimates an emerging impact in terms of disability and reducing the quality of life worldwide, particularly for the aging populations. One of the root causes of this decline is likely to derive from the interaction of socio-environmental risk...

Funding Programme
Start Date
End Date
Total Funding
€ 3 619 635
European Countries Involved

affecTive basEd iNtegrateD carE for betteR Quality of Life

TeNDER

With an increasingly growing population in Europe, cognitive impairments as well as heart diseases are a major social and health issue. 1.2 million people in Europe are affected by Parkinson's disease (PD) while Alzheimer’s disease remains one of the biggest global public health challenges our generation is facing, while Cardiovascular disease...

Funding Programme
Start Date
End Date
Total Funding
€ 5 698 333
European Countries Involved

ALzheimer COoperative Valuation in Europe

The JA will be contribute to public health programmes in Europe and develop Alzheimers disease (AD) and dementia prevention and care models in different European countries. The aim is to contribute to improvements in health by supporting and facilitating quality and efficiency of public health and healthcare policies and interventions. Synergy and...

Funding Programme
Start Date
End Date
Total Funding
€ 613 100

Amyloid-β clearance in Alzheimer's disease: Unravelling the role of endocytic pathways of endothelial cells

ClearPath

Alzheimer’s disease (AD) is an age-associated, irreversible neurodegenerative disorder. Α fundamental neuropathological hallmark of this disease is the accumulation of the amyloid-beta (Aβ) peptide in the extracellular space and its aggregation in the brain. Interestingly, critical role for a healthy brain is played by clearance mechanisms of...

Funding Programme
Start Date
End Date
Total Funding
€ 169 326
European Countries Involved

ARTIFICIAL INTELLIGENCE BASED HEALTH, OPTIMISM, PURPOSE, AND ENDURANCE IN PALLIATIVE CARE FOR DEMENTIA

AI4HOPE

Dementia is caused by a range of illnesses and disorders that damage the brain either directly or indirectly. With the rise of the ageing population in the EU, dementia is becoming a serious problem. Digital health interventions have the potential to improve the accessibility and effectiveness of palliative care. Palliative care is an area where...

Funding Programme
Start Date
End Date
Total Funding
€ 6 419 025

Bioengineered microbes as a platform for discovering chemical rescuers of disease-related misfolding of integral membrane proteins

ProMisMe

Protein misfolding diseases (PMDs) are a large group of human disorders caused by the misfolding of specific proteins. They include conditions with high socio-economic impact, such as Alzheimer’s disease, cystic fibrosis, obesity and type 2 diabetes, and the majority of them remain incurable. Among the >70 PMDs, about 1/3 are caused by misfolding...

Funding Programme
Start Date
End Date
Total Funding
€ 211 658
European Countries Involved

Consortium on Health and Ageing: Network of Cohorts in Europe and the United States

CHANCES

CHANCES aims at combining and integrating on-going cohort studies in order to produce evidence on ageing-related health characteristics and determinants in Europe, and their socio-economic implications. 15 cohorts participate, covering populations from 18 EU Member States, 4 associate countries, and 3 additional countries. The combination of these...

Funding Programme
Start Date
End Date
Total Funding
€ 15 410 903

Deep-Learning and HPC to Boost Biomedical Applications for Health

DeepHealth

Health scientific discovery and innovation are expected to quickly move forward under the so called “fourth paradigm of science”, which relies on unifying the traditionally separated and heterogeneous high-performance computing and big data analytics environments. Under this paradigm, the DeepHealth project will provide HPC computing power at the...

Funding Programme
Start Date
End Date
Total Funding
€ 14 642 324
European Countries Involved

Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes

DORIAN GRAY

DORIAN GRAY project investigates the link between cardiovascular disease (CVD) and Mild Cognitive Impairment (MCI) in the ageing population. Its goal is to uncover underlying mechanisms to promote healthy, independent, and active living while reducing disease burden. Aligned with EU-Horizon Europe’s Strategic Plan on NCDs prevention, the project...

Funding Programme
Start Date
End Date
Total Funding
€ 10 921 114
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).